SHENZHEN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced the appointment of Mr. Minghe Cheng as Chief Strategic Officer of the Company, effective as of September 6, 2010. Mr. Cheng's role will primarily include business model development, short and long-term strategic program planning and corporate structure and operation-process optimization.
"Mr. Cheng's extensive breadth of experience with Mindray's strategy and development makes him the ideal choice for this position," commented Mr. Xu Hang, Mindray's Chairman and Co-Chief Executive Officer. "We are confident that Mr. Cheng will continue to add value to Mindray's brand and play an instrumental role in helping the company benefit from new business and market opportunities."
"I look forward to my new role in developing both short and long-term strategic plans for each of our existing product lines as well as searching for new opportunities to aid the rapid and healthy expansion of Mindray's overall business," added Mr. Minghe Cheng. "There is great potential for Mindray, and given our innovative approach and strategic thinking backed by effective operations, we believe we are well-positioned to capitalize on these new opportunities."
As a co-founder of Mindray, Mr. Cheng has served 17 years in various roles across Mindray's sales, marketing and strategic development departments since the Company's establishment. Mr. Cheng received his bachelor's and master's degrees in biomedical engineering from Shanghai Jiaotong University.
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .
For investor and media inquiries, please contact: In the U.S.: Bryan Armstrong FD Tel: +1-312-553-6707 Email: firstname.lastname@example.org John Capodanno FD Tel: +1-212-850-5705 Email: email@example.com In China: Cathy Gao Tel: +86-755-2658-2518 Email: firstname.lastname@example.org
|SOURCE Mindray Medical International Limited|
Copyright©2010 PR Newswire.
All rights reserved